Publications by authors named "Michael Laska"

Claim this Profile
P
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses.
Kapil Bahl, Joe J Senn, Olga Yuzhakov, Alex Bulychev, Luis A Brito, Michael E Laska

Mol Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials.
Robert A Feldman, Rainard Fuhr, Igor Smolenov, Amilcar Mick Ribeiro, Lori Panther, Michael E Laska

Vaccine· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety Evaluation of Lipid Nanoparticle-Formulated Modified mRNA in the Sprague-Dawley Rat and Cynomolgus Monkey.
Maja Sedic, Joseph J Senn, Andy Lynn, Michael Laska, Mike Smith

Vet Pathol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses.
Kapil Bahl, Joe J Senn, Olga Yuzhakov, Alex Bulychev, Luis A Brito, Michael E Laska

Mol Ther· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robust scale-up of dead end filtration: impact of filter fouling mechanisms and flow distribution.
Michael E Laska, Ralph P Brooks, Marshall Gayton, Narahari S Pujar

Biotechnol Bioeng· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serotype specificity of adenovirus purification using anion-exchange chromatography.
John O Konz, Rebecca C Livingood, Andrew J Bett, Aaron R Goerke, Michael E Laska

Hum Gene Ther· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis